Unparalleled Clinical Research Expertise in Type 1 and Type 2 Diabetes
ProSciento was founded based on a mission to find better therapeutic treatments for individuals with diabetes. This long-standing commitment has evolved into a portfolio of metabolism-focused services, methodologies and capabilities to enable highly informative multinational trials for new diabetes drugs and devices.
We offer clients unparalleled expertise in diabetes clinical research. Our broad experience encompasses nearly all clinically relevant diabetes drug classes covering all routes of administration and many medical device development programs, including continuous glucose monitoring devices, insulin pumps and artificial pancreas systems.
Our Diabetes Compound and Device Experience – A Few Examples:
- Insulin secretagogues
- Insulin sensitizers
- Incretin/glucagon pathway modulators
- SGLT-2 inhibitors
- Incretins mimetics
- Glucoregulatory peptides & proteins
- Immune-modulation & beta cell regeneration
- Artificial pancreas
- Continuous glucose monitoring systems (CGMS)
- Peptide administration
- mHealth applications